SCHEMBL6157334

SCHEMBL6157334

CCOC(=O)C(C)C(Br)C(=O)OCC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
TRPA1 O75762 1/20 0.41
LMNA P02545 1/20 0.40
HSD17B10 Q99714 1/20 0.40
ALOX15 P16050 1/20 0.39
MGAM O43451 1/20 0.39
GAA P10253 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
SOAT1 P35610 1/20 0.39
PIN1 Q13526 1/20 0.33
HPGD P15428 1/20 0.33
POLB P06746 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
MEN1 O00255 1/20 0.32
NPC1 O15118 1/20 0.32
KMT2A Q03164 1/20 0.32
CAD P27708 1/20 0.32
MMP8 P22894 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1415615 0.85 ALDH1A1 (0.50) ALDH1A1TRPA1LMNAHSD17B10ALOX15
SCHEMBL22144315 0.85 ALDH1A1 (0.50) ALDH1A1TRPA1LMNAHSD17B10ALOX15
SCHEMBL1731339 0.83 ALDH1A1 (0.43) ALDH1A1TRPA1LMNAHSD17B10ALOX15
SCHEMBL19327412 0.83 ALDH1A1 (0.43) ALDH1A1TRPA1LMNAHSD17B10ALOX15
SCHEMBL1733288 0.83 ALDH1A1 (0.43) ALDH1A1TRPA1LMNAHSD17B10ALOX15
SCHEMBL9834260 0.83 ALDH1A1 (0.43) ALDH1A1TRPA1LMNAHSD17B10ALOX15
SCHEMBL89146 0.83 ALDH1A1 (0.43) ALDH1A1TRPA1LMNAHSD17B10ALOX15
SCHEMBL19318891 0.82 ALDH1A1 (0.53) ALDH1A1TRPA1LMNAHSD17B10ALOX15
SCHEMBL12640198 0.82 ALDH1A1 (0.53) ALDH1A1TRPA1LMNAHSD17B10ALOX15
SCHEMBL9753730 0.81 ALDH1A1 (0.42) ALDH1A1TRPA1LMNAHSD17B10ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6953789-B2 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2005-10-11 US disclosed
US-20040157894-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-08-12 US disclosed
US-6699881-B2 MATRIX METALLOPROTEASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2004-03-02 US disclosed
US-20030078253-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY, LIMITED (JP) 2003-04-24 US disclosed
US-6420415-B1 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-07-16 US disclosed
EP-1132379-A1 NOVEL THIOL DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF Takeda Chemical Industries, Ltd. (JP) 2001-09-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078253-A1 Thiol compounds, their production and use TST, QSOX1, SULT1E1 ALDH1A1 905/4885TRPA1 1117/4885LMNA 4373/4885
US-20040157894-A1 Thiol compounds, their production and use TST, SULT1E1, QSOX1 ALDH1A1 877/4885TRPA1 1258/4885LMNA 4464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.